# Efficacy and Tolerability of the Use of Varicell Compared With Daflon

> **NCT01321619** · PHASE3 · UNKNOWN · sponsor: **Vidfarma Indústria de Medicamentos Ltda.** · enrollment: 102 (estimated)

## Conditions studied

- Chronic Venous Insufficiency
- Hemorrhoids

## Interventions

- **DRUG:** Daflon
- **DRUG:** Varicell placebo

## Key facts

- **NCT ID:** NCT01321619
- **Lead sponsor:** Vidfarma Indústria de Medicamentos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01321619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01321619, "Efficacy and Tolerability of the Use of Varicell Compared With Daflon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01321619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*